Mechanisms of nordihydroguaiaretic acid-induced growth inhibition and apoptosis in human cancer cells

British Journal of Cancer

Volumn 86, Issue 7, 2002, Pages 1188-1196

  Seufferlein, Thomas ^a   Seckl, M J ^d   Schwarz, E ^b   Beil, M ^a   Wichert, G V ^a   Baust, H ^a   Luhrs H ^c   Schmid, R M ^a   Adler, G ^a  

^a UNIVERSITY OF ULM   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Actin cytoskeleton; Apoptosis; Cervical cancer; JNK; NDGA; Pancreatic cancer

Indexed keywords

NORDIHYDROGUAIARETIC ACID;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARACHIDONIC ACID METABOLISM; ARTICLE; CELL SURVIVAL; CYTOSKELETON; DRUG USE; GROWTH INHIBITION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; UTERINE CERVIX CANCER;

ACTINS; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL ADHESION; CELL DIVISION; CYTOSKELETON; FEMALE; HUMANS; LIPOXYGENASE INHIBITORS; MICE; NORDIHYDROGUAIARETIC ACID; PANCREATIC NEOPLASMS; PROTEIN KINASES; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS;

EID: 0037041632     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600186     Document Type: Article

References (50)

1. A role for MAPK/ERK in sympathetic neuron survival: Protection against a p53-dependent, JNK-independent induction of apoptosis by cytosine arabinoside
2. Growth control of lung cancer by interruption of 5-lipoxygenase-mediated growth factor signaling
3. Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation
4. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms
5. Induction of apoptosis by the transcription factor c-Jun
6. Control of p70 s6 kinase by kinase activity of FRAP in vivo
7. Positive correlation between histological tumour involvement and generation of tumour cell colonies in agarose in specimens taken directly from patients with small cell carcinoma of the lung
8. Induction of c-fos expression through JNK-mediated TCF/Elk-1 phosphorylation
9. Differential effects of putative lipoxygenase inhibitors on arachidonic acid metabolism in cell-free and intact cell preparations
10. The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and γ radiation
11. Evidence that the cytoskeleton plays a role in cell adhesion
12. The 70 kDa S6 kinase: Regulation of a kinase with multiple roles in mitogenic signalling
13. Bradykinin induces actin reorganization and enhances cell motility in HaCaT keratinocytes
14. Cellular survival: A play in three AKTs
15. Arachidonic acid and eicosanoids as targets and effectors in second messenger interactions
16. Lipoxygenase inhibitors abolish proliferation of human pancreatic cancer cells
17. Lipoxygenase inhibition induced apoptosis, morphological changes, and carbonic anhydrase expression in human pancreatic cancer cells
18. Preferential inhibition of platelet-derived growth factor-stimulated DNA synthesis and protein tyrosine phosphorylation by nordihydroguaiaretic acid
19. s6k
20. Disruption of epithelial cell-matrix interactions induces apoptosis
21. A role for Jun-N-terminal kinase in anoikis; suppression by bcl-2 and crmA
22. Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells
23. s6K pathway in human pancreatic cancer cells
24. TNF induces c-fos via a novel pathway requiring conversion of arachidonic acid to a lipoxygenase metabolite
25. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells
26. Stimulation of p38 phosphorylation and activity by arachidonic acid in HeLa cells, HL60 promyelocytic leukemic cells, and human neutrophils. Evidence for cell type-specific activation of mitogen-activated protein kinases
27. An inhibitor of lipoxygenase, nordihydroguaiaretic acid, shortens actin filaments
28. 2-terminal kinase and induction of apoptosis after detachment of epithelial cells
29. Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha
30. Inhibition of basal and mitogen-stimulated pancreatic cancer cell growth by cyclin D1 antisense is associated with loss of tumourigenicity and potentiation of cytotoxicity to cisplatinum
31. Ras promotes cell survival in Drosophila by down-regulating hid expression
32. Protein kinase cascades activated by stress and inflammatory cytokines
33. Arachidonic acid activates Jun N-terminal kinase in vascular smooth muscle cells
34. Lovastatin inhibits proliferation of pancreatic cancer cell lines with mutant as well as with wild-type K-ras oncogene but has different effects on protein phosphorylation and induction of apoptosis
35. Insulin-like growth factor 1 inhibits apoptosis using the phosphatidylinositol 3′-kinase and mitogen-activated protein kinase pathways
36. Epidermal growth factor activates calcium channels by phospholipase A2/5-lipoxygenase-mediated leukotriene C4 production
37. Nordihydroguaiaretic acid inhibits urokinase synthesis by phorbol myristate acetate-stimulated LLC-PK1 cells
38. Signal transduction pathways in the mitogenic response to G protein-coupled neuropeptide receptor agonists
39. Cisplatin induces a persistent activation of JNK that is related to cell death
40. Transforming growth factor alpha activates Ha-ras in human pancreatic cancer cells with Ki-ras mutations
41. Platelet-activating factor both stimulates and 'primes' human polymorphonuclear leukocyte actin filament assembly
42. Mammalian G1 cyclins
43. Inhibition of Myc-dependent apoptosis by eukaryotic translation initiation factor 4E requires cyclin D1
44. Enhanced expression of urokinase receptor induced through the tissue factor-factor VIIa pathway in human pancreatic cancer
45. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway
46. Effects of antioxidants on cyclooxygenase and lipoxygenase activities in intact human platelets: Comparison with indomethacin and ETYA
47. Requirement for ceramide-initiated SAPK/JNK signaling in stress-induced apoptosis
48. Relevance of cyclin D1 and other molecular markers to cancer chemoprevention
49. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis
50. The stress activated protein kinase pathway mediates cell death following injury induced by cis-platinum, UV irradiation or heat